Clinical trial
A Phase 1 Dose Escalation Study to Assess the Safety and Immunogenicity of a Monovalent Virus-Like Particle (VLP) Venezuelan Equine Encephalitis Vaccine in Healthy Adults
NCT03776994 is registered in ClinicalTrials.gov with SRI International as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Dose Escalation Study to Assess the Safety and Immunogenicity of a Monovalent Virus-Like Particle (VLP) Venezuelan Equine Encephalitis Vaccine in Healthy Adults
- Lead sponsor
- SRI International
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- July 17, 2018
- Completion date
- April 30, 2021
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alphavirus infections, brain diseases, central nervous system diseases, central nervous system infections, central nervous system viral diseases, encephalitis, encephalitis, viral, encephalomyelitis, encephalomyelitis, equine, encephalomyelitis, venezuelan equine, infectious encephalitis, nervous system diseases, physiological effects of drugs, rna virus infections, togaviridae infections, vaccines, virus diseases